Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 3
446
Views
10
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Structure-activity relationship of atorvastatin derivatives for metabolic activation by hydrolases

, , , , &
Pages 261-269 | Received 03 Apr 2019, Accepted 26 May 2019, Published online: 19 Jun 2019
 

Abstract

1. We investigated the structure-activity relationship of 31 kinds of synthesized atorvastatin esters, thioesters, amides and lactone, selected as prodrug models, for metabolic activation by microsomes and hydrolases.

2. The susceptibility to human carboxylesterase 1 (hCES1) was influenced not only by the size of the acyl group and alkoxy group but also by the degree of steric crowding around the alkoxy group.

3. The susceptibility to human carboxylesterase 2 (hCES2) increased with a decrease in electron density around the alkoxy group of the substrate.

4. Lactone was specifically hydrolyzed by paraoxonase 3 (PON3).

5. These findings should be useful in prodrug design for controlling metabolic activation.

Acknowledgments

The authors thank the HAB Research Organization (Japan) for providing human livers.

Disclosure statement

The authors declare that there is no conflict of interest.

Additional information

Funding

This work was supported by JSPS KAKENHI Grant Number JP17K15519 and JP16K08378.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.